Opti Laboratories are the UK experts in lash and brow growth. We’re founded and led by a team of UK-based doctors, and our Lash Growth Treatment is our flagship product. Scientific innovation is at the core of everything we do.
The Opti Laboratories Lash Growth Treatment has been clinically proven to grow lashes up to 25% longer, 106% thicker and 18% darker. Because it has been through a rigorous, FDA-led testing process, the treatment can only be bought as a prescription. After purchasing, you’ll need to submit a form for review by our doctors.
Our Sun Protect Serum is available without prescription, and doesn’t contain the active ingredient that directly stimulates growth within the Growth Treatment. It is, however, the world’s first serum to contain sun protection for lashes and brows. Sun exposure can break down keratin and protein bonds, weakening hair and causing breakage; it is one of the primary causes of hair damage.
The Sun Protect serum can improve the health and condition of your lashes and contribute to normal healthy growth. Used alongside the Growth Treatment, lashes will be significantly longer, thicker and healthier.
Both products work as efficiently on brows. The treatment can transform fine vellus hairs into thick, “real”, hairs; this effect is usually sufficient to fill gaps in sparse or overplucked brows.
The Opti Laboratories Growth Treatment contains an active ingredient, bimatoprost. Bimatoprost is a prostaglandin analogue, a synthetic version of a class of naturally occurring molecules. Prostaglandins are a bit like hormones – a signal that your body uses to regulate processes like hair growth.
Your lashes grow in a cycle with three phases:
Anagen (active growth phase)
Catagen (transition phase)
Telogen (resting phase)
The bimatoprost in the Growth Treatment mimics the body’s natural signals, extending the anagen phase of the lash’s growth. As a result, your eyelashes grow for a longer period of time, resulting in thicker, stronger, and longer lashes.
The growth treatment derives from a medical glaucoma eye drop, sold under the brand name “Lumigan”.
The eye drop contains an ophthalmic solution of 0.03% bimatoprost. patients using Lumigan for glaucoma, found that they grew longer, thicker and darker eyelashes than usual.
This is because the bimatoprost was soaking into the hair follicles closest to where it was applied (to the eye), and caused those hairs to enter their anagen, or growth, phase. The individual hairs grew thicker and longer than normal, and the increased thickness resulted in a darker appearance to each hair.
Lumigan was soon approved for use as an eyelash growth treatment. It has FDA approval, and the FDA’s clinical trials found that the eyelashes were on average 106% thicker, 25% longer and 18% darker after consistent use. Most users see results within 4 weeks but the best results take 16 weeks to appear. This is because the growth cycle for all of your eyelashes take 16 weeks on average to go through the growth phase.
The approved solution, containing the same 0.03% bimatoprost, is sold for use in the UK by Opti Laboratories. It is clinically proven to be both safe and effective.
Opti Laboratories only sells the treatment under online consultation with one of our UK-based doctors. You don’t need to have a medical reason for using the treatment, and it is compatible with lash extensions and strip lashes if you’re using it as a complementary treatment.
The Growth Treatment is not the same as an eyelash serum. Serums, like our world-first Sun Protect Serum, can be bought directly, without medical consultation. This is because they don’t contain an active growth ingredient.
Serums can condition your lashes and so contribute to normal, healthy growth, but they don’t directly cause growth.
Anything that contains an active growth ingredient will require a prescription, so be wary of claims that a product will grow your lashes if it’s available to buy without a medical form.
It is very rare to experience side effects using the Growth Treatment and, in our experience, if they do occur it is often due to incorrect application.
In clinical trials, less than 2% of users experienced irritation or redness. Our customers experience side effects more rarely still, because our application technology is more precise than that used in the clinical trial. Examples of these rare side effects include:
